“BIM.D reduces excessive TNF-α, IFN-γ and IL-17 which is the cause type 1 and type 2 diabetes.”
The BIM.D special formula is the latest formula to support a balanced immunity & thus ensure optimal immune system response in relation to type-1 & type-2 diabetes.
BIM.D supplements main active ingredient is a proprietary mangosteen extract, ‘GM-1’, discovered by lead scientist Dr Pichaet Wiriyachitra. GM-1 was found to be the most active xanthones to be extracted from mangosteen amongst 41 xanthones.
Scientific studies of Xanthones has been proven to have unique characteristics including;
- Growth inhibition and the ability to kill antibiotic-resistant gram-positive bacteria, the effectiveness equals that of vancomycin.
- Anti-inflammatory, 3 times as effective as aspirin.
- Analgesic (pain relieving) and anti-allergy.
- Anti-oxidant – preventing heart diseases from LDL cholesterol oxidation.
- Kills breast cancer cells, leukemia cells, liver cancer cells, kidney cancer cells, stomach/intestinal cancer cells, and lung cancer cells (based on laboratory testing).
- Kill tuberculosis bacterium (based on laboratory testing).
- Inhibit the propagation of HIV (based on laboratory testing).
- Increase the phagocytosis, the cellular process of eliminating foreign matters and bacteria.
- Inhibit cartilage deterioration and increase bone mass (based on laboratory testing)
Other natural ingredients included in BIM.d include extracts from Soybean, Centella Asiatica, sesame, Guava which is certified from Food and Drug administration to be safe supplement with no side effects.
BIM.D Research & Development
BIM.D has been researched & developed over the past 30 years by a scientist team led by Dr Pichaet Wiriyachitra, as a way to optimize immune system response in relation to immune system related health issues including type-1 diabetes & type-2 diabetes.
These health issues are known to be the cause of excessive production of TNF-α, IFN-y and IL-17. BIM.D merely acts to counter this by lowering the production of these cytokines (TNF-α, IFN-y and IL-17).
Type-1 & Type-2 Diabetes Study
In type 1 diabetes, the immune system which normally fights harmful bacteria or viruses – attacks and destroys the insulin-producing Beta cells in the pancreas (autoimmunity). This type of diabetes results from the loss of the insulin-producing beta cells produced by the pancreas, leading to insulin deficiency. Type 1 diabetes can be classified as an autoimmune disease in which the T-cells destroy the beta cells.
Type 2 diabetes is when the insulin receptors in the body cells do not respond properly to the insulin. Insulin is the substance that helps bring glucose, as a source of energy, to the cells in our bodies. Therefore, people who suffer from diabetes have high blood sugar (glucose) and ineffective insulin. If high blood sugar levels persist for a long time, this will damage blood vessels and nerve ending system. If diabetes is not properly treated it can lead to other diseases such as difficulty in the healing of wounds, cardiovascular disease, kidney problems, blurred vision and stroke.
The white blood cells of diabetic patients secrete too much TNF-α, IFN-ƴ and IL-17, creating an overbalanced immunity. In the case of type 1 diabetes the oversupply of TNF-α and IFN-y destroys the beta cells in the pancreas, reducing the natural production of insulin. Due to the oversupply of TNF-α and IFN-y in type 2 diabetes, the body cells will resist the natural insulin in the body. The oversupply of IL-17 will empower the body’s auto-immunity, which in turn increases the severity of the diabetes and its associated symptoms.
BIM.D Clinical Studies
Volunteers who took 4 BIM.D capsules per day for 15 days significantly lowered their TNF-α, lower INF-γ and lower IL-17.
A decrease of TNF-α, INF-γ and IL-17 reduces the severity of type 1 and type 2 diabetes. BIM.D also lowers cholesterol and blood pressure.
*Clinical studies on the effects of BIM.D capsules done at the Biomedical Technology Research Centre